Development and assessment of an engineered cardiac tissue for treating dilated cardiomyopathy
Ended Project Grant Awarded Last action
- Award ID
- R43HL144332
- Recipient
-
Avery Therapeutics Inc. UEI EAEKFAHSBLQ1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,998
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Arizona, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,998 |
Quick answers
Who received award R43HL144332?
R43HL144332 was awarded to Avery Therapeutics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on May 15, 2019.
How much is award R43HL144332 worth?
$299,998 has been obligated on R43HL144332.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award